Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART)
Stopped early
Conditions studied: Sperm DNA Impact on ART Outcomes
In brief
The purpose of this study is to establish a new criteria with which to judge the quality of sperm samples submitted for artificial reproductive treatments. It is believed that this type of testing can compliment the traditional semen analysis to better drive patient care.
Key facts
- Study ID
- NCT00875095
- Run by
- Northwell Health
- People needed
- 8
- Starts
- 2007-10-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2016-09-08
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- needs interventions through artificial reproductive treatment to achieve a pregnancy
You may not qualify if…
- severly oligozoospermic patients
Where it is running
- The Center for Human Reproduction — Manhasset, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.